@FierceBiotech: Analysts jolted by Pharmasset's stellar data on combo hep C treatment. News | Follow @FierceBiotech
@JohnCFierce: I'll be taking off for Rome tomorrow, on way to BIO Europe for biotech panel discussion. Follow @JohnCFierce
> Amylin, Eli Lilly and Alkermes announced positive results from a Phase II study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes. Release
> Exelixis, which has a promising cancer therapy dubbed cabozantinib in Phase III, is raising $165 million through a stock sale. Report
> BioCryst Pharmaceuticals has added to its runway with a $30 million financing deal. Story
> Adamis Pharmaceuticals is recruiting 30 men for the first human clinical trial of its prostate cancer therapy. Story
Pharma News
@FiercePharma: Lilly CEO: No need for megadeals, we have Japan. Story | Follow @FiercePharma
> KV's Makena delivers $1,500 sticker shock to docs. Report
> Merck KGaA chief seeks to repair investor relations. Article
> GSK, Human Genome gear up for Benlysta launch. News
> Bloomberg: Pfizer's ex-CEO in running for cabinet post. Report
> Roche keeps up DTC on Boniva while others cut. Story
> U.K. docs: Almost half of J&J hip devices fail after 6 years. Item
Vaccines News
> Cancer vax developer Kite lands $15M. Story
> Gates steps in to vaccine VC with $10M investment. Item
> Virus present up to one month after Zostavax immunization. Report
> BiovaxID gets EMA orphan status. News
> Japan: No link between child deaths, vaccines. Article
Manufacturing News
> Bill elevates drug theft to organized crime status. News
> FDA works to avert cancer drug shortage. Report
> J&J shortage links eBay to drug supply chain. Item
> Study finds fuzzy price/drug-quality link. Report
> Demand, speculators threaten Chinese medicine plants. Article
And Finally... Researchers have recently shown that, rather than being the silent creatures of popular belief, mice emit ultrasonic calls in a variety of social contexts, and these calls have song-like characteristics. Release